Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas

被引:549
作者
Mansvelder, HD
Keath, JR
McGehee, DS
机构
[1] Univ Chicago, Dept Anesthesia & Crit Care, Chicago, IL 60637 USA
[2] Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA
关键词
D O I
10.1016/S0896-6273(02)00625-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
A single nicotine exposure increases dopamine levels in the mesolimbic reward system for hours, but nicotine concentrations experienced by smokers desensitize nAChRs on dopamine neurons in seconds to minutes. Here, we show that persistent modulation of both GABAergic and glutamatergic synaptic transmission by nicotine can contribute to the sustained increase in dopamine neuron excitability. Nicotine enhances GABAergic transmission transiently, which is followed by a persistent depression of these inhibitory inputs due to nAChR desensitization. Simultaneously, nicotine enhances glutamatergic transmission through nAChRs that desensitize less than those on GABA neurons. The net effect is a shift toward excitation of the dopamine reward system. These results suggest that spatial and temporal differences in nicotinic receptor activity on both excitatory and inhibitory neurons in reward areas coordinate to reinforce nicotine self-administration.
引用
收藏
页码:905 / 919
页数:15
相关论文
共 69 条
  • [1] Nicotine at concentrations found in cigarette smokers activates and desensitizes nicotinic acetylcholine receptors in CA1 interneurons of rat hippocampus
    Alkondon, M
    Pereira, EFR
    Almeida, LEF
    Randall, WR
    Albuquerque, EX
    [J]. NEUROPHARMACOLOGY, 2000, 39 (13) : 2726 - 2739
  • [2] Nicotinic receptor activation in human cerebral cortical interneurons: a mechanism for inhibition and disinhibition of neuronal networks
    Alkondon, M
    Pereira, EFR
    Eisenberg, HM
    Albuquerque, EX
    [J]. JOURNAL OF NEUROSCIENCE, 2000, 20 (01) : 66 - 75
  • [3] Alkondon M, 1999, J NEUROSCI, V19, P2693
  • [4] Alkondon M, 1997, J PHARMACOL EXP THER, V283, P1396
  • [5] ALKONDON M, 1992, MOL PHARMACOL, V41, P802
  • [6] ALKONDON M, 1993, J PHARMACOL EXP THER, V265, P1455
  • [7] Blaha CD, 1996, J NEUROSCI, V16, P714
  • [8] Bonci A, 1999, J NEUROSCI, V19, P3723
  • [9] Camara AL, 1997, NEUROTOXICOLOGY, V18, P589
  • [10] Cameron A.C., 1998, Regression Analysis of Count Data, V30